Skip to content
Sanatan Upmanyu

Publications.

Peer-reviewed work and granted patents in AI for drug discovery, immuno-oncology, and molecular biology.

Papers

  1. 2022

    DeAngelis, M., Wilkinson, E., Anant, M., Sharma, S., Vijayadamodar, G., Upmanyu, S., Ganjoo, A., Alesci, S., Kant, A., & Nandabalan, K. (2022). AI-based deconvolution of the gut-brain axis (GBA) and its therapeutic implications.

    Gastroenterology, 162(7-S), 760
  2. 2017

    Rastelli, L., Gupta, S., Dahiya, A., Jagga, Z., Nandabalan, K., & Upmanyu, S. (2017). The synergy between BXCL701, a DPP inhibitor, and immune checkpoint inhibitors discovered using AI and Big Data analytics.

    AACR; Cancer Res, 77(13 Suppl), Washington, DC
  3. 2015

    Sheetal, K., Upmanyu, S., Sharma, H., & Nandabalan, K. (2015). Targeting immune checkpoints: using a big data approach for their identification, prioritization and application.

    AACR 106th Annual Meeting, Philadelphia, PA
  4. 2010

    Tiwari, P., Saini, S., Upmanyu, S., Benjamin, B., Tandon, R., Saini, K. S., & Sahdev, S. (2010). Enhanced expression of recombinant proteins utilizing a modified baculovirus expression vector.

    Molecular Biotechnology, 46, 80-89
  5. 2009

    Tiwari, P., Saini, S., Upmanyu, S., Saini, K. S., & Sahdev, S. (2009). Enhanced expression of kinases and cyp-450 enzymes through a modified Baculovirus expression vector for oncology research.

    Poster, International Symposium on Cancer Chemoprevention, JNU, New Delhi

Patents

  • US20180134771
    Novel Immunomodulatory Therapeutic Strategies Targeting Tumors in Cancer
    United States Patent and Trademark Office
    View on Google Patents
  • US20190008918
    Immunomodulation Therapies for Cancer
    United States Patent and Trademark Office
    View on Google Patents